WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
QUICK SEARCH:   [advanced]


     
-


HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP
The Journal of Neuroscience, October 24, 2007, 27(43):11758-11768; doi:10.1523/JNEUROSCI.2461-07.2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strand, A. D.
Right arrow Articles by Jones, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Strand, A. D.
Right arrow Articles by Jones, K. R.

 Previous Article  |  Next Article 

Neurobiology of Disease
Expression Profiling of Huntington's Disease Models Suggests That Brain-Derived Neurotrophic Factor Depletion Plays a Major Role in Striatal Degeneration

Andrew D. Strand,1 * Zachary C. Baquet,2 * Aaron K. Aragaki,1 Peter Holmans,3 Lichuan Yang,5 Carine Cleren,6 M. Flint Beal,5 Lesley Jones,3,4 Charles Kooperberg,1 James M. Olson,1 {ddagger} and Kevin R. Jones2 {ddagger}

1Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, 2Department of Molecular, Cellular and Developmental Biology, University of Colorado at Boulder, Boulder, Colorado 80309, 3Department of Psychological Medicine and 4Institute of Medical Genetics, Wales School of Medicine, Cardiff University, Cardiff CF14 4XN, United Kingdom, 5Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York 10021, and 6Laboratoire de Neurobiologie, Faculte des Sciences de l'Universite de Nice Sophia-Antipolis, 06108 Nice Cedex 2, France

Correspondence should be addressed to Andrew Strand, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109. Email: astrand{at}fhcrc.org

Many pathways have been proposed as contributing to Huntington's disease (HD) pathogenesis, but generally the in vivo effects of their perturbation have not been compared with reference data from human patients. Here we examine how accurately mechanistically motivated and genetic HD models recapitulate the striatal gene expression phenotype of human HD. The representative genetic model was the R6/2 transgenic mouse, which expresses a fragment of the huntingtin protein containing a long CAG repeat. Pathogenic mechanisms examined include mitochondrial dysfunction; profiled in 3-nitropropionic acid-treated rats, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice, and PGC-1{alpha} knock-out mice; and depletion of brain-derived neurotrophic factor (BDNF) using heterozygous and forebrain-specific BDNF-knock-out mice (BDNFHET, Emx-BDNFKO). Based on striatal gene expression, we find the BDNF models, both heterozygous and homozygous knock-outs, to be more like human HD than the other HD models. This implicates reduced trophic support as a major pathway contributing to striatal degeneration in HD. Because the majority of striatal BDNF is synthesized by cortical neurons, the data also imply that cortical dysfunction contributes to HD's hallmark effects on the basal ganglia. Finally, the results suggest that striatal lesions caused by mitochondrial toxins may arise via pathways different from those that drive neurodegeneration in HD. Based on these findings, we present a testable model of HD pathogenesis that, unlike most models, begins to account for regional specificity in human HD and the absence of such specificity in genetic mouse models of HD.

Key words: Huntington's disease; neurotrophin; microarray; polyglutamine; striatum; neurodegeneration; BDNF

Received May 30, 2007; revised Sept. 13, 2007; accepted Sept. 14, 2007.

Correspondence should be addressed to Andrew Strand, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109. Email: astrand{at}fhcrc.org


Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2007 27: i. [Full Text]  





-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help
-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-